Gerhard T, Chavez B, Olfson M, Crystal S.  2009.  National Patterns in the Outpatient Pharmacological Management of Children and Adolescents with Autism Spectrum Disorder. Journal of Clinical Psychopharmacology. 29(3):307-309. Abstract

Bitterman A, Daley TC, Misra S, Carlson E, Markowitz J.  2008.  A National Sample of Preschoolers with Autism Spectrum Disorders: Special Education Services and Parent Satisfaction. J Autism Dev Disord. 38(8):1509-1517.

Chiang H-M.  2009.  Naturalistic Observations of Elicited Expressive Communications of Children with Autism: An Analysis of Teacher Instructions. Autism. 13(2):165-178. Abstract

Kouijzer MEJ, deMoor JMH, Gerrits BJL, Congedo M, vanSchie HT.  2009.  Neurofeedback Improves Executive Functioning in Children with Autism Spectrum Disorders. Research in Autism Spectrum Disorders. 3:145-162.

Jacobs EH.  2005.  Neurofeedback Treatment of Two Children with Learning, Attention, Mood, Social, and Developmental Deficits. Journal of Neuropathy. 9(4):55-70.

Waterhouse L, Fein D, Modahl C.  1996.  Neurofunctional Mechanisms in Autism. Psychol Rev.. 103:457-489.

Zecavati N, Spence SJ.  2009.  Neurometabolic Disorders and Dysfunction in Autism Spectrum Disorders. Current Neurology and Neuroscience Reports. 9(2):129-136.

Friedlander AH, Yagiela JA, Paterno VA, Mahler ME.  2006.  The Neuropathology, Medical Management, and Dental Implications of Autism. Journal of the American Dental Association. 137(11):1517-1527.

Heinrichs M, Domes G.  2008.  Neuropeptides and Social Behavior: Effects of Oxytocin and Vasopressin in Humans. Progress in Brain Research. 170:337-350.

Dwyer DS, Dickson A.  2007.  Neuroprotection and Enhancement of Neurite Outgrowth with Small Molecular Weight Compounds from Screens of Chemical Libraries. International Review of Neurobiology. 77:247-289.

Schmahmann JD, Weilburg JB, Sherman JC.  2007.  The Neuropsychiatry of the Cerebellum – Insights from the Clinic. The Cerebellum. 6(3):254-267.

Troost PW, Althaus M, Lahuis BE, Buitelaar JK, Minderaa RB, Hoekstra PJ.  2006.  Neuropsychological Effects of Risperidone in Children with Pervasive Developmental Disorders: A Blinded Discontinuation Study. Journal of Child and Adolescent Psychopharmacology. 16(5):561-573.

Bartz JA, Hollander E.  2006.  The Neuroscience of Affiliation: Forging Links between Basic and Clinical Research on Neuropeptides and Social Behavior. Hormones and Behavior. 50(4):518-528.

Bertoglio K, Hendren RL.  2009.  New Developments in Autism. Psychiatr Clin N Am. 32(1):1-14. Abstract

Dillenburger K, Keenan M.  2009.  None of the As in ABA Stand for Autism: Dispelling the Myths. Journal of Intellectual & Developmental Disability . 34(2):193-195. Abstract

Silverman MJ.  2008.  Nonverbal Communication, Music Therapy, and Autism: A Review of Literature and Case Example. Journal of Creativity in Mental Health. 3(1):3-19. Abstract

Theoharides TC, Doyle R, Francis K, Conti P, Kalogeromitros D.  2008.  Novel Therapeutic Targets for Autism. Trends in Pharmacological Sciences. 29(8):375-382.

Levy SE, Hyman SL.  2005.  Novel Treatments for Autistic Spectrum Disorders. Mental Retardation and Developmental Disabilities Research Reviews. 11:131-142.

Curtis LT, Patel K.  2008.  Nutritional and Environmental Approaches to Preventing and Treating Autism and Attention Deficit Hyperactivity Disorder (ADHD): A Review. The Journal of Alternative and Complementary Medicine. 14(1)